Ziganshina, G. Et Al. 2021. Ceftriaxone decreases lung cancer inflammation though targeting priming of NLRP3 . Central Asia Genomics Symposium 2021 , (Toskent, Uzbekistan), 1.

Ziganshina, G., Alsaadi, M., Tezcan, G., Hamza, S., Rizvanov, A. A., & Khaiboullina, S. F., (2021). Ceftriaxone decreases lung cancer inflammation though targeting priming of NLRP3 . Central Asia Genomics Symposium 2021 (pp.1). Toskent, Uzbekistan

Ziganshina, Gulshat Et Al. "Ceftriaxone decreases lung cancer inflammation though targeting priming of NLRP3 ," Central Asia Genomics Symposium 2021, Toskent, Uzbekistan, 2021

Ziganshina, Gulshat Et Al. "Ceftriaxone decreases lung cancer inflammation though targeting priming of NLRP3 ." Central Asia Genomics Symposium 2021 , Toskent, Uzbekistan, pp.1, 2021

Ziganshina, G. Et Al. (2021) . "Ceftriaxone decreases lung cancer inflammation though targeting priming of NLRP3 ." Central Asia Genomics Symposium 2021 , Toskent, Uzbekistan, p.1.

@conferencepaper{conferencepaper, author={Gulshat Ziganshina Et Al. }, title={Ceftriaxone decreases lung cancer inflammation though targeting priming of NLRP3 }, congress name={Central Asia Genomics Symposium 2021}, city={Toskent}, country={Uzbekistan}, year={2021}, pages={1} }